Nash, P., Mease, P., Fleishaker, D., Wu, J., Coates, L., Behrens, F., . . . Kanik, K. (2020). Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: A randomised, placebo-controlled substudy of OPAL Balance. Elsevier.
Cytowanie według stylu Chicago (wyd. 17)Nash, P., et al. Tofacitinib as Monotherapy Following Methotrexate Withdrawal in Patients with Psoriatic Arthritis Previously Treated with Open-label Tofacitinib Plus Methotrexate: A Randomised, Placebo-controlled Substudy of OPAL Balance. Elsevier, 2020.
Cytowanie według stylu MLA (wyd. 9)Nash, P., et al. Tofacitinib as Monotherapy Following Methotrexate Withdrawal in Patients with Psoriatic Arthritis Previously Treated with Open-label Tofacitinib Plus Methotrexate: A Randomised, Placebo-controlled Substudy of OPAL Balance. Elsevier, 2020.